BioSpace, the leader in biopharma news and careers, has revealed the 2026 cohort for its second 40 Under 40 list. BioSpace's ...

Big Pharma companies including Bristol Myers Squibb, Johnson & Johnson and Novartis are among those that made or planned layoffs in Q3. Those cuts could affect over 1,800 employees, with New Jersey ...

Venture capital continued to flow into biopharma in the third quarter, though experts pointed out that investors remained ...

BioSpace announced its "40 Under 40" list on Tuesday, recognizing a group of young professionals for their contributions to ...

On October 5, 2026, Shionogi & Co., Ltd. announced that it would acquire the US-based rare disease drug company IntraBio for ...

Multiply Labs’ $75 million Series B is a bet that robots can make advanced medicines affordable at industrial scale. Arriving ...

Erasca is now a fully funded fast follower in RAS-targeted oncology, with ~$1B pro forma liquidity and three potential ...

A strategic letter of intent with an established U.S. 503A compounding pharmacy gives The More Life Company (CSE: MLCO, OTC: ...

Gilead Sciences stock (ISIN US3755581036) was trading at USD 147.94 on Nasdaq on October 7, 2026, up 2.57 percent from USD ...

- $107.50 level represents critical technical support; a positive 304 readout could break through resistance, while a miss risks rapid downside.

The agreement, announced Monday, gives Genentech exclusive development and commercialization rights to AL050 across all ...

WuXi AppTec received the EcoVadis Gold Medal for the third consecutive year on October 7, 2026, while first-half revenue rose ...